V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10313089 | 10039273 | 1.87 | 78.6 | Not known (9) | 2019-05-18 | 2019-05-30 | Sunitinib | 02 | null | DABRAFENIB + TRAMETINIB | 101087261 |
| 10313232 | 10039275 | 1.64 | 112.4 | null | 2018-11-12 | 2018-11-12 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | TRIAL | 101558007 |
| 10313310 | 10039277 | 1.49 | 0 | Palliative (P) | 2018-10-15 | 2018-10-16 | DARATUMUMAB | 02 | N | DABRAFENIB + TRAMETINIB | 101189353 |
| 10313335 | 10039278 | 1.71 | 83 | null | 2017-09-28 | 2017-10-03 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100964619 |
| 10313452 | 10039280 | 1.61 | null | Palliative (P) | 2019-10-11 | 2019-10-11 | CISPLATIN + VINORELBINE | 01 | N | SUNITINIB | 101377929 |
| 10313483 | 10039281 | null | 0 | null | 2019-07-31 | 2019-08-08 | CVP R | 02 | null | POMALIDOMIDE | 101398465 |
| 10313565 | 10039283 | 1.65 | 108 | null | null | 2021-11-01 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 100325474 |
| 10313570 | 10039284 | 1.57 | 82.6 | Palliative (P) | 2019-04-10 | 2019-04-13 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100359168 |
| 10313622 | 10039285 | 1.68 | 75.6 | Adjuvant (A) | 2019-02-27 | 2019-03-05 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101528136 |
| 10313627 | 10039286 | 0 | 58 | Palliative (P) | 1996-05-26 | 2018-03-09 | CHOP R | 02 | N | CHOP R | 101322459 |
| 10313656 | 10039288 | 1.77 | 89.5 | Curative (C) | 2019-12-23 | 2019-12-23 | Avelumab | 2 | null | AVELUMAB | 100444283 |
| 10313721 | 10039289 | 1.85 | 94.2 | Curative (C) | 2018-07-03 | 2018-07-03 | BCG Intravesical | 02 | N | CLADRIBINE | 100935160 |
| 10313725 | 10039290 | 1.73 | 78.3 | Curative (C) | 2019-03-06 | 2019-03-14 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100641301 |
| 10313878 | 10039291 | 1.72 | 54.2 | null | 2018-09-27 | 2018-10-18 | CLADRIBINE | N | null | CAPECITABINE + GEMCITABINE | 100567521 |
| 10313910 | 10039292 | null | 74 | Curative (C) | 2019-02-26 | 2019-03-10 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100403667 |
| 10313990 | 10039294 | 1.72 | 95.3 | 03 | 2017-08-10 | 2017-08-20 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101272565 |
| 10314027 | 10039295 | null | 59.9 | null | 2021-10-24 | 2021-12-09 | DABRAFENIB + TRAMETINIB | 02 | null | CISPLATIN + FLUOROURACIL | 101036460 |
| 10314034 | 10039296 | 1.62 | 85.55 | null | 2016-07-14 | 2016-08-14 | Avelumab | 02 | null | AVELUMAB | 100080711 |
| 10314040 | 10039297 | null | null | Palliative (P) | 2017-02-11 | 2017-02-25 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101155920 |
| 10314120 | 10039299 | 1.82 | 64.1 | null | 2022-04-05 | 2022-04-06 | DARATUMUMAB | N | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100363131 |
| 10314132 | 10039300 | 1.71 | 73 | Curative (C) | 2019-03-09 | 2019-03-16 | POMALIDOMIDE | 02 | null | BUSULFAN | 101747448 |
| 10314145 | 10039301 | 1.77 | 65 | null | 2020-04-24 | 2020-05-13 | CTD Attenuated (Thalidomide 50mg) | N | null | CYTARABINE | 100846270 |
| 10314210 | 10039303 | 1.8 | 81 | Palliative (P) | 2018-07-10 | 2018-07-22 | Capecitabine + Cisplatin | N | N | POMALIDOMIDE | 101197256 |
| 10314257 | 10039305 | null | null | null | 2018-09-24 | 2018-09-24 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101705102 |
| 10314291 | 10039306 | 1.62 | null | Neo-adjuvant (N) | 2017-11-05 | 2017-11-12 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | N | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101273926 |
| 10314302 | 10039307 | 1.72 | 60 | Adjuvant (A) | 2020-07-24 | 2020-07-25 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101500828 |
| 10314342 | 10039308 | 1.6 | 91.3 | null | 2018-08-26 | 2019-08-15 | Avelumab | 02 | null | AVELUMAB | 101083073 |
| 10314422 | 10039309 | 1.86 | 76.4 | Palliative (P) | null | 2016-07-30 | R GCVP | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100917660 |
| 10314558 | 10039311 | 1.69 | 103.2 | Curative (C) | 2019-07-26 | 2019-08-11 | CHOP | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100466669 |
| 10314573 | 10039312 | 1.59 | 62.9 | Curative (C) | 2021-03-22 | 2021-03-22 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100345449 |
| 10314734 | 10039314 | 1.76 | 80.4 | null | 2019-03-24 | 2019-03-24 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | null | Y | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100914467 |
| 10314744 | 10039315 | null | null | null | 2018-12-18 | 2019-01-11 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101623976 |
| 10314776 | 10039316 | 1.69 | 87.4 | 03 | 2019-08-18 | 2019-09-01 | Sunitinib | 02 | N | DABRAFENIB + TRAMETINIB | 100233325 |
| 10314785 | 10039317 | 1.64 | 60.6 | Curative (C) | 2018-08-30 | 2021-04-02 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 100239859 |
| 10314938 | 10039319 | 1.56 | 95 | Curative (C) | 2018-05-22 | 2018-06-05 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101693462 |
| 10315039 | 10039323 | 1.52 | null | null | 2017-11-25 | 2017-12-10 | Avelumab | N | null | AVELUMAB | 101789852 |
| 10315065 | 10039324 | 1.7 | 71.3 | null | 2019-11-04 | 2019-11-11 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100343035 |
| 10315137 | 10039326 | 1.71 | 75 | Adjuvant (A) | 2018-08-03 | 2018-08-03 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100308680 |
| 10315172 | 10039327 | 1.87 | 51 | null | 2022-03-10 | 2022-03-16 | EOX | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100768167 |
| 10315209 | 10039328 | 1.88 | 83.9 | Curative (C) | 2019-11-02 | 2019-11-28 | CHOP R + Prednisolone | 02 | N | CHOP R | 100154729 |
| 10315224 | 10039329 | 1.69 | 82 | Curative (C) | 2019-04-08 | 2019-04-17 | FEC 60 or 75 | 2 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101234373 |
| 10315262 | 10039330 | null | 0 | null | 2022-02-05 | 2022-02-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100501485 |
| 10315272 | 10039331 | 1.74 | 82 | Curative (C) | 2018-02-22 | 2018-05-23 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 2 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101680651 |
| 10315276 | 10039332 | 1.6 | 66 | null | 2019-08-02 | 2019-08-02 | Cisplatin + Vinorelbine (PO) | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101802191 |
| 10315425 | 10039335 | 1.73 | 83.6 | Palliative (P) | 2018-11-10 | 2018-11-10 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100870188 |
| 10315429 | 10039337 | 1.8 | 67.5 | 03 | 2019-08-12 | 2019-08-22 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101619819 |
| 10315465 | 10039338 | null | 90 | null | 2018-11-01 | 2018-11-12 | DABRAFENIB + TRAMETINIB | 02 | null | BUSULFAN | 100888441 |
| 10315485 | 10039339 | 1.67 | null | Palliative (P) | 2019-01-11 | 2019-01-29 | CLADRIBINE | 02 | N | VENETOCLAX | 100857408 |
| 10315491 | 10039340 | 1.54 | 73 | Palliative (P) | 2020-07-16 | 2020-07-17 | EOX | 2 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101332629 |
| 10315523 | 10039341 | 1.62 | 74.4 | 03 | 2018-09-04 | 2018-09-04 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101759330 |